Description

(S)-1-(4-(2-(6-Amino-8-(6-Bromobenzo[D][1,3]Dioxol-5-Ylthio)-9H-Purin-9-Yl)Ethyl)Piperidin-1-Yl)-2-Hydroxypropan-1-One Trifluoroacetate is a high-purity, non-natural nucleoside analog derivative designed for advanced research and development. This compound is a critical building block in medicinal chemistry, offering a unique structural motif for targeting specific biological pathways. It is primarily utilized by pharmaceutical R&D teams and biotech companies engaged in the discovery of novel therapeutic agents.

Application

• Pharmaceutical Research & Development: Serves as a key intermediate or active pharmaceutical ingredient (API) precursor in the synthesis of novel drug candidates.
• Medicinal Chemistry: Used as a sophisticated scaffold for structure-activity relationship (SAR) studies, particularly in oncology and antiviral research.
• Biochemical Research: Functions as a tool compound for investigating enzyme inhibition, receptor binding, and other cellular mechanisms.
• Process Chemistry Development: Employed in optimizing synthetic routes and scaling up production for preclinical and clinical studies.
• Contract Research Organizations (CROs): Supplied to CROs supporting drug discovery programs for client pharmaceutical companies.
• Academic Research: Used in university laboratories for cutting-edge research in chemical biology and therapeutic discovery.

Basic Information

Product Name	(S)-1-(4-(2-(6-Amino-8-(6-Bromobenzo[D][1,3]Dioxol-5-Ylthio)-9H-Purin-9-Yl)Ethyl)Piperidin-1-Yl)-2-Hydroxypropan-1-One Trifluoroacetate
CAS No.	958025-67-7
Molecular Formula	C22H24BrN7O4S • C2HF3O2
Molecular Weight	Contact for details
Synonyms	(S)-1-[4-[2-[6-Amino-8-[(6-bromo-1,3-benzodioxol-5-yl)sulfanyl]-9H-purin-9-yl]ethyl]piperidin-1-yl]-2-hydroxypropan-1-one; 2,2,2-Trifluoroacetic acid compound with (1S)-1-[4-[2-[6-amino-8-[(6-bromo-1,3-benzodioxol-5-yl)sulfanyl]-9H-purin-9-yl]ethyl]-1-piperidinyl]-2-hydroxy-1-propanone (1:1); 958025-67-7; (S)-1-(4-(2-(6-Amino-8-(6-Bromobenzo[D][1,3]Dioxol-5-Ylthio)-9H-Purin-9-Yl)Ethyl)Piperidin-1-Yl)-2-Hydroxypropan-1-One TFA Salt; Purine derivative CAS 958025-67-7.
EINECS	Contact for details

Quality Control

Our (S)-1-(4-(2-(6-Amino-8-(6-Bromobenzo[D][1,3]Dioxol-5-Ylthio)-9H-Purin-9-Yl)Ethyl)Piperidin-1-Yl)-2-Hydroxypropan-1-One Trifluoroacetate is manufactured under strict quality systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and NMR for structural confirmation, to ensure it meets the high standards required for pharmaceutical research. A comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store at -20°C or below in a dry environment. This product is hygroscopic (moisture-sensitive) and should be handled under anhydrous conditions to maintain stability and purity. Allow the sealed container to reach room temperature before opening to minimize moisture condensation.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (HPLC)	Conforms
Identification (NMR)	Conforms
Purity (HPLC)	≥ 95.0%
Single Impurity (HPLC)	≤ 1.0%
Total Impurities (HPLC)	≤ 5.0%
Water Content (KF)	≤ 1.0%
Residual Solvents (GC)	Meets ICH guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.